I have two minor issues with the wording, firstly I don’t like the excuse about difficult circumstances relating to Covid-19 when this type of product should probably get an enormous opportunity from the current circumstances and social distancing. Secondly, I don’t like the justification of a low initial uptake being intentional to allow evolution to fix any problems as the launch was already more than 6 months overdue, any issues should have already been ironed out. I would prefer a more positive attitude about the opportunity of external circumstances and a sense of responsibility about results. Otherwise no surprises.
- Forums
- ASX - By Stock
- Ann: Quarterly Update and Appendix 4C
AHI
advanced health intelligence ltd
Add to My Watchlist
0.00%
!
9.2¢

I have two minor issues with the wording, firstly I don’t like...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
9.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $25.81M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AHI (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online